Spreadex Market Update

Meta's Stock Crashes, USDJPY Crosses 155



Equities

On Wednesday, Britain's FTSE 100 index reversed earlier gains and closed slightly lower, down by 0.1%, ending a five-day winning streak. This was influenced by a poor performance update from chemicals group Croda, which fell 4.8% after reporting a 10% drop in first-quarter group sales and reiterating a gloomier profit outlook for the year. Luxury retailer Burberry also contributed to the downtrend, dropping 2.6% following a profit warning from its rival, French luxury goods company Kering.

Shares in mining giants like Rio Tinto, Anglo American, and Glencore enjoyed increases of between 1.2% and 4.5%, buoyed by an uptick in metal prices. This helped to keep overall losses more contained. Additionally, Reckitt Benckiser added 2.9% as its quarterly like-for-like sales growth surpassed estimates. Management expressed optimism that reduced price sensitivity among consumers might lead to greater preference for Reckitt’s premium brands over less expensive alternatives.

Across the pond in the United States, the S&P 500 ended a choppy trading session slightly higher, with a marginal increase of 0.02%. This came despite an uptick in Treasury yields, following an auction of a record $70 billion worth of five-year US Treasury notes, which initially put pressure on equities. The tech-heavy Nasdaq Composite also finished the day in positive territory, increasing by 0.10%, while the Dow Jones Industrial Average fell by 0.11%.

Meta Platforms experienced a significant drop, falling 11% in extended hours trading after disclosing that its capital expenditure for 2024 could reach up to $40 billion, overshadowing a revenue beat. Tesla shares, however, jumped 12% following news of planned production increases and the introduction of more affordable vehicle models. Other companies like Boeing and Enphase Energy reported mixed results with Boeing shares falling 2.8% and Enphase Energy dropping 5.5%.

In the tech sector, anticipation is building around forthcoming earnings reports from major players such as Microsoft and Alphabet, which are expected to provide further direction for the market. Meanwhile, Texas Instruments saw a rise of 5.6% after forecasting second-quarter revenue above analyst expectations, contributing to a positive close for the Philadelphia Semiconductor Index. Biogen and Boston Scientific also reported strong earnings, with their shares climbing 4.5% and 5.7% respectively, thanks to earnings that surpassed forecasts. Lastly, Hasbro’s shares climbed nearly 12% after the toymaker reported less severe sales declines than expected and exceeded profit estimates.

Forex & Commodities

The Japanese yen weakened against the US dollar, dropping to 155.26, which is its lowest since the mid-1990s. This move reflects broader strength in the US dollar, which also saw its index rise modestly by 0.2% to 105.84. In contrast, the euro remained stable at $1.0697, and the British pound increased slightly by 0.1% to $1.2460.

Gold prices remained steady at $2,322 per ounce, following a decrease from a record high earlier in the month. Notably, traders are pricing in a 70% chance of a US rate cut by September, which could impact non-yielding assets like gold.

Oil prices showed a decline, with Brent crude falling to $88.02 a barrel and West Texas Intermediate crude dropping to $82.81. Despite this, a significant draw in US crude inventories provided some support against further losses.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.